Literature DB >> 16386183

[Prospective 2-year clinical study of patients with positive IgG-antibodies after recovering from severe acute respiratory syndrome].

Cheng-hong Yin1, Chao Wang, Yan Wen, Li Jiang, Qin Lu, Jing-ling Li, Jing Wang, Zheng-yi He, Shu-wen Zhang, Bao-en Wang.   

Abstract

OBJECTIVE: To investigate the clinical characteristics of patients recovering from severe acute respiratory syndrome (SARS) during 2 years after the infection.
METHODS: The antibody of SARS-IgG, T cell subsets, chest CT, and the pulmonary function were observed in patients 1 month, 3 months, 6 months, and 2 years after convalescence from SARS.
RESULTS: In the 20 SARS cases, the level of antibodies was found to descend gradually and slowly during 2 years after convalescence. In the majority of patients T cell subsets recovered completely to normal range at the second examination. At the first re-examination, the rate of abnormal chest CT was 65%, and the main abnormal images included ground glass opacities, thickening of inter-lobular and intra-lobular septa, distorted lobular structure, thickened bronchovascular bundles, thickened pleura, arc shadow under the pleura, bronchiolar dilation, and honey comb like shadows. The rate of abnormal chest CT was 30% at the 4 fourth examination. At the first re-examination, the abnormal rate of KCO was highest, accompanied by abnormalities of forced expiratory volume in 1 second (FEV1) and the diffusing capacity of the lung for carbon monoxide (DLCO), and it began to recover since the third examination.
CONCLUSION: The level of SARS-IgG descends slowly, and it may last for a long time. The recovery of chest CT to normal may take a long time. The abnormality in pulmonary functions manifests mainly as impairment of diffusion function. Further research on SARS is necessary.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16386183

Source DB:  PubMed          Journal:  Zhongguo Wei Zhong Bing Ji Jiu Yi Xue        ISSN: 1003-0603


  3 in total

1.  Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?

Authors:  Jinglu Lyu; Tianyu Miao; Jiajia Dong; Ranran Cao; Yan Li; Qianming Chen
Journal:  Med Hypotheses       Date:  2020-05-15       Impact factor: 1.538

2.  Applying the WHO ICF Framework to the Outcome Measures Used in the Evaluation of Long-Term Clinical Outcomes in Coronavirus Outbreaks.

Authors:  Kajal Patel; Sofia Straudi; Ng Yee Sien; Nora Fayed; John L Melvin; Manoj Sivan
Journal:  Int J Environ Res Public Health       Date:  2020-09-05       Impact factor: 3.390

3.  Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information.

Authors:  Halie M Rando; Tellen D Bennett; James Brian Byrd; Carolyn Bramante; Tiffany J Callahan; Christopher G Chute; Hannah E Davis; Rachel Deer; Joel Gagnier; Farrukh M Koraishy; Feifan Liu; Julie A McMurry; Richard A Moffitt; Emily R Pfaff; Justin T Reese; Rose Relevo; Peter N Robinson; Joel H Saltz; Anthony Solomonides; Anupam Sule; Umit Topaloglu; Melissa A Haendel
Journal:  medRxiv       Date:  2021-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.